KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | -68.6% | 13,137 | -27.9% | 0.01% | -72.2% |
| Q2 2021 | $188,000 | -62.0% | 18,229 | -61.3% | 0.02% | -48.6% |
| Q1 2021 | $495,000 | -36.1% | 47,054 | -6.1% | 0.04% | -58.3% |
| Q4 2020 | $775,000 | +682.8% | 50,086 | +387.8% | 0.08% | +950.0% |
| Q3 2019 | $99,000 | -49.2% | 10,267 | -10.5% | 0.01% | -33.3% |
| Q3 2018 | $195,000 | -41.3% | 11,466 | -53.6% | 0.01% | -33.3% |
| Q1 2018 | $332,000 | +65.2% | 24,710 | +35.1% | 0.02% | +80.0% |
| Q3 2017 | $201,000 | – | 18,293 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |